Report Detail
Global Triptorelin Drug Market Insights, Forecast to 2025
- RnM3498611 |
- 06 June, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur®, is a GnRH agonist analogue. An agonist is a chemical that binds to a receptor of a cell and triggers a response by that cell. Triptorelin decreases the serum testosterone to castrate levels (estradiol in females).
The global Triptorelin Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Triptorelin Drug market based on company, product type, end user and key regions.
This report studies the global market size of Triptorelin Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Triptorelin Drug in these regions.
This research report categorizes the global Triptorelin Drug market by top players/brands, region, type and end user. This report also studies the global Triptorelin Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Allergan
Debiopharm Group
Ipsen
Xbrane Biopharma
Chengdu Tiantaishan pharmaceutical
Arbor Pharmaceuticals
Ferring
Market size by Product
3.75 mg Vial
11.25 mg Vial
22.5 mg Vial
Market size by End User
Advanced prostate cancer
Endometriosis
Uterine fibroids
Precocious puberty
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Triptorelin Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Triptorelin Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Triptorelin Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Triptorelin Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Triptorelin Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Triptorelin Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Triptorelin Drug Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Triptorelin Drug Market Size Growth Rate by Product
- 1.4.2 3.75 mg Vial
- 1.4.3 11.25 mg Vial
- 1.4.4 22.5 mg Vial
- 1.5 Market by End User
- 1.5.1 Global Triptorelin Drug Market Size Growth Rate by End User
- 1.5.2 Advanced prostate cancer
- 1.5.3 Endometriosis
- 1.5.4 Uterine fibroids
- 1.5.5 Precocious puberty
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Triptorelin Drug Market Size
- 2.1.1 Global Triptorelin Drug Revenue 2014-2025
- 2.1.2 Global Triptorelin Drug Sales 2014-2025
- 2.2 Triptorelin Drug Growth Rate by Regions
- 2.2.1 Global Triptorelin Drug Sales by Regions
- 2.2.2 Global Triptorelin Drug Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Triptorelin Drug Sales by Manufacturers
- 3.1.1 Triptorelin Drug Sales by Manufacturers
- 3.1.2 Triptorelin Drug Sales Market Share by Manufacturers
- 3.1.3 Global Triptorelin Drug Market Concentration Ratio (CR5 and HHI)
- 3.2 Triptorelin Drug Revenue by Manufacturers
- 3.2.1 Triptorelin Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Triptorelin Drug Revenue Share by Manufacturers (2014-2019)
- 3.3 Triptorelin Drug Price by Manufacturers
- 3.4 Triptorelin Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Triptorelin Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Triptorelin Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Triptorelin Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Triptorelin Drug Sales by Product
- 4.2 Global Triptorelin Drug Revenue by Product
- 4.3 Triptorelin Drug Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Triptorelin Drug Breakdown Data by End User
6 North America
- 6.1 North America Triptorelin Drug by Countries
- 6.1.1 North America Triptorelin Drug Sales by Countries
- 6.1.2 North America Triptorelin Drug Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Triptorelin Drug by Product
- 6.3 North America Triptorelin Drug by End User
7 Europe
- 7.1 Europe Triptorelin Drug by Countries
- 7.1.1 Europe Triptorelin Drug Sales by Countries
- 7.1.2 Europe Triptorelin Drug Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Triptorelin Drug by Product
- 7.3 Europe Triptorelin Drug by End User
8 Asia Pacific
- 8.1 Asia Pacific Triptorelin Drug by Countries
- 8.1.1 Asia Pacific Triptorelin Drug Sales by Countries
- 8.1.2 Asia Pacific Triptorelin Drug Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Triptorelin Drug by Product
- 8.3 Asia Pacific Triptorelin Drug by End User
9 Central & South America
- 9.1 Central & South America Triptorelin Drug by Countries
- 9.1.1 Central & South America Triptorelin Drug Sales by Countries
- 9.1.2 Central & South America Triptorelin Drug Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Triptorelin Drug by Product
- 9.3 Central & South America Triptorelin Drug by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Triptorelin Drug by Countries
- 10.1.1 Middle East and Africa Triptorelin Drug Sales by Countries
- 10.1.2 Middle East and Africa Triptorelin Drug Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Triptorelin Drug by Product
- 10.3 Middle East and Africa Triptorelin Drug by End User
11 Company Profiles
- 11.1 Allergan
- 11.1.1 Allergan Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Allergan Triptorelin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Allergan Triptorelin Drug Products Offered
- 11.1.5 Allergan Recent Development
- 11.2 Debiopharm Group
- 11.2.1 Debiopharm Group Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Debiopharm Group Triptorelin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Debiopharm Group Triptorelin Drug Products Offered
- 11.2.5 Debiopharm Group Recent Development
- 11.3 Ipsen
- 11.3.1 Ipsen Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Ipsen Triptorelin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Ipsen Triptorelin Drug Products Offered
- 11.3.5 Ipsen Recent Development
- 11.4 Xbrane Biopharma
- 11.4.1 Xbrane Biopharma Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Xbrane Biopharma Triptorelin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Xbrane Biopharma Triptorelin Drug Products Offered
- 11.4.5 Xbrane Biopharma Recent Development
- 11.5 Chengdu Tiantaishan pharmaceutical
- 11.5.1 Chengdu Tiantaishan pharmaceutical Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Chengdu Tiantaishan pharmaceutical Triptorelin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Chengdu Tiantaishan pharmaceutical Triptorelin Drug Products Offered
- 11.5.5 Chengdu Tiantaishan pharmaceutical Recent Development
- 11.6 Arbor Pharmaceuticals
- 11.6.1 Arbor Pharmaceuticals Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Arbor Pharmaceuticals Triptorelin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Arbor Pharmaceuticals Triptorelin Drug Products Offered
- 11.6.5 Arbor Pharmaceuticals Recent Development
- 11.7 Ferring
- 11.7.1 Ferring Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Ferring Triptorelin Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Ferring Triptorelin Drug Products Offered
- 11.7.5 Ferring Recent Development
12 Future Forecast
- 12.1 Triptorelin Drug Market Forecast by Regions
- 12.1.1 Global Triptorelin Drug Sales Forecast by Regions 2019-2025
- 12.1.2 Global Triptorelin Drug Revenue Forecast by Regions 2019-2025
- 12.2 Triptorelin Drug Market Forecast by Product
- 12.2.1 Global Triptorelin Drug Sales Forecast by Product 2019-2025
- 12.2.2 Global Triptorelin Drug Revenue Forecast by Product 2019-2025
- 12.3 Triptorelin Drug Market Forecast by End User
- 12.4 North America Triptorelin Drug Forecast
- 12.5 Europe Triptorelin Drug Forecast
- 12.6 Asia Pacific Triptorelin Drug Forecast
- 12.7 Central & South America Triptorelin Drug Forecast
- 12.8 Middle East and Africa Triptorelin Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Triptorelin Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Triptorelin Drug . Industry analysis & Market Report on Triptorelin Drug is a syndicated market report, published as Global Triptorelin Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Triptorelin Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
